A Multiplex Human Pluripotent Stem Cell Platform Defines Molecular and Functional Subclasses of Autism-Related Genes

Lorenz Studer, M.D.
Southern California Stem Cell Consortium (SCSCC)
Lorenz Studer, M.D. profile photo with Cell Stem Cell Press cover

Date and time

April 8, 2021

9:30 AM - 10:30 AM PT



“Breaking News in Stem Cells” is the only lecture series that brings the top papers in the field to your desktop as they happen

This month, Lorenz Studer, M.D., will present his paper as published in the July 2020 issue of Cell Stem Cell.


Hosted by:

Evan Snyder, M.D., Ph.D.
Human Genetics Program
Director for Center for Stem Cells and Regenerative Medicine
Sanford Children’s Health Research Center


Lorenz Studer, M.D.
Director for Center for Stem Cell Biology
Memorial Sloan Kettering Cancer Center

Dr. Studer's laboratory aims at exploiting recent advances in stem cell biology to develop radically new therapies for degenerative disease and cancer.
The main focus in the lab is on the biology and application of human embryonic stem (ES) and human induced pluripotent (iPS) cells. Pluripotent stem cells can provide a truly unlimited source for deriving therapeutically relevant cell types for applications in human disease modeling or regenerative medicine.

A major effort of the lab is devoted to harnessing and manipulating the differentiation potential of human pluripotent stem cells. We have developed highly efficient strategies to coax human pluripotent stem cells into specific brain cell populations in a dish. Specific types of nerve cells that are routinely generated in the lab include midbrain dopamine neurons, motoneurons, GABA+ interneurons, and sensory neurons.